Recent News

• 09.16.2025 - CFO Felipe Duran Leads iBio’s Financial Strategy With Agility and Vision
• 09.05.2025 - iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
• 09.05.2025 - iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
• 08.25.2025 - iBio Announces Closing of $50 Million Public Offering
• 08.19.2025 - iBio Announces Pricing of $50 Million Public Offering
• 08.19.2025 - iBio Announces Pricing of $50 Million Public Offering
• 08.18.2025 - iBio Announces Proposed Public Offering
• 08.18.2025 - iBio Announces Proposed Public Offering

Recent Filings

• 09.05.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 09.05.2025 - EX-99.1 EX-99.1
• 09.05.2025 - 8-K Current report
• 08.26.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.25.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.21.2025 - EX-99.1 EX-99.1
• 08.21.2025 - 8-K Current report
• 08.21.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.18.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.18.2025 - EX-99.1 EX-99.1